Purchase Order 75N95025P00381
- Not listed
- <p>The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a $24,900 firm fixed price purchase order contract to Pelago Bioscience AB, a for-profit limited liability company. The contract is for the development of a new assay to test compounds of interest. The period of performance runs from the award date of September 9, 2024 through September 8, 2025. This contract award does not have a set-aside designation.</p>
- <p>The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a $2,600.00 firm fixed-price purchase order contract to Neurostatus-Uhb AG, a foreign-owned for-profit organization, for a NeuroStatus e-test license and EDSS training. The contract has an ultimate completion date of December 31, 2025 and was awarded on January 1, 2025. The contract was not set aside for any specific business designation.</p>
- The U.S. National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services' National Institutes of Health, awarded a $24,000.00 Labor Hour Purchase Order contract to Pearson Pharma Partners, a small business, to provide a Subject Matter Expert Consultant in Drug Metabolism Pharmacokinetics (DMPK) to support the NIH Blueprint Neurotherapeutics Network program. The one-year base period contract has an estimated minimum of 20 annual hours and a not-to-exceed maximum of...
- The National Institute on Drug Abuse awarded a firm fixed-price purchase order to Rashid Adnan (UEI: LMD7VXK1MQV9) on March 6, 2020, with a ceiling value of $26,900. The contract, which was solicited without a set-aside designation, calls for the awardee to study the pathophysiology and develop related research deliverables, with work to be performed in Greenbelt, Maryland. The solicitation was posted on January 31, 2020, with a bid due date of February 14, 2020, and the contract ultimately...
- The U.S. National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services' National Institutes of Health, awarded a $19,600.00 Purchase Order contract to Lin Jiunn, a small business located in Ambler, Pennsylvania. The contract is for a Subject Matter Expert Consultant in Drug Metabolism Pharmacokinetics (DMPK) to support NIDA's NIH Blueprint Neurotherapeutics Network program. The contract has a one-year base period with an estimated minimum of 20 annual hours and a...
- The National Institute on Drug Abuse (NIDA) awarded a $15.4K firm fixed-price purchase order to Becton, Dickinson and Company (BD), operating through its BDB Division as BD Biosciences, for custom conjugation services to support ongoing laboratory studies. The contract, awarded on September 9, 2025, will be performed in Baltimore, Maryland, with an ultimate completion date of September 8, 2026. This procurement was conducted on a full and open basis without small business set-aside...
- This is a firm fixed-price purchase order awarded by the Headquarters Division of a civilian federal agency to NCS Pearson, Inc., a foreign-owned for-profit organization that specializes in educational and clinical assessment products and services. The $15,980.00 contract was awarded on April 16, 2018 with a completion date of September 30, 2018. The contract is not set aside. NCS Pearson is the largest provider of educational assessment services in the United States and holds exclusive...
- The National Institute on Drug Abuse (NIDA), under the Office of the Director, awarded a Blanket Purchase Agreement (BPA) call valued at $12.5K to Corporate Press Incorporated for the development and production of educational materials related to drug abuse treatment resources. The contract, designated CSA #PPQ10239 under the title "Seeking Drug Abuse Treatment: Know What to Ask," was awarded on September 13, 2011, with a completion date of August 31, 2012. The work was performed in...
- The National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, awarded a $120,969.12 firm-fixed-price delivery order contract to 22nd Century Technologies, Inc., a minority-owned small business. The contract is part of the Scientific, Operations, and Administrative Resources (SOAR) multiple-award indefinite-delivery/indefinite-quantity (IDIQ) contract valued at $3.6 billion, which provides a wide range of information technology products,...
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $14,104.50 firm fixed price purchase order to Carahsoft Technology Corp. to deliver 5,000 Qualtrics survey responses in support of research as described in the attached statement of work. Carahsoft will perform the work as the prime contractor in Baltimore, Maryland between July 2023 and September 2024. No set aside designation or subcontractors were indicated. This purchase...
The National Institute on Drug Abuse (NIDA) awarded a $23,006 firm fixed-price purchase order to NCS Pearson, Inc. on September 4, 2025, for the procurement of copyrighted psychological assessment questionnaires. Specifically, NIDA's Intramural Research Program requires the Beck Anxiety Inventory (BAI), Beck Depression Inventory-II (BDI-II), and Childhood Trauma Questionnaire (CTQ) to support ongoing clinical protocols and research activities. These standardized assessment instruments are essential for measuring anxiety, depression, and trauma exposure in study participants. The contract was awarded without set-aside designation and carries an ultimate completion date of November 3, 2025, with performance to be conducted in Baltimore, Maryland. NCS Pearson, Inc., headquartered in Austin, Texas, is a leading provider of psychological and educational assessment products and services to federal agencies. The company maintains an extensive portfolio of federal contracts spanning multiple departments, including the Department of Veterans Affairs, Department of Defense, and U.S. Special Operations Command, demonstrating established capability in delivering clinical assessment tools and scoring services. This purchase order represents a straightforward transactional acquisition of copyrighted assessment materials necessary for NIDA's ongoing research mission, consistent with the agency's focus on drug abuse research and clinical evaluation methodologies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.0k | 9/4/25 |